Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry
- 30 April 2020
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 225, 88-96
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (K01HL133416–01)
- Amgen
- Sanofi
- Regeneron Pharmaceuticals
- National Institutes of Health (5 T32 HL069749–14)
This publication has 18 references indexed in Scilit:
- Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registryAmerican Heart Journal, 2015
- Standards of Medical Care in Diabetes—2015: Summary of RevisionsDiabetes Care, 2014
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsCirculation, 2014
- Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: Comparison by prevalent cardiovascular disease statusDiabetes & Vascular Disease Research, 2013
- The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010Diabetes Care, 2013
- American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: Executive SummaryEndocrine Practice, 2012
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. PopulationDiabetes Care, 2006
- The Continuing Epidemics of Obesity and Diabetes in the United StatesJAMA, 2001
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)BMJ, 1998